IQVIA Holdings Inc. Common Stock vs Marvell Technology Inc — how do they compare? IQVIA Holdings Inc. Common Stock trades at $259.95 (market cap $42.61B), while Marvell Technology Inc trades at $275.05 (market cap $246.84B). The key difference: Marvell Technology Inc is far larger — about 5.8× IQVIA Holdings Inc. Common Stock's market cap, and Marvell Technology Inc pays a 0.09% dividend while IQVIA Holdings Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold IQVIA Holdings Inc. Common Stock for 1 Days and Marvell Technology Inc for 42 Days on average.
| IQV | MRVL | |
|---|---|---|
Market Cap | $42.61B | $246.84B |
Volume | 988,398 | 29,003,830 |
Sector | Health | Technology |
52-Week High | $275.02 | $316.43 |
52-Week Low | $156.66 | $73.73 |
Typical Hold Time | 1 Days | 42 Days |
Enterprise Value | $56.77B | $248.19B |
Dividend Yield | — | 0.09% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Marvell Technology (MRVL) trades at $275.28, down 3.3% in the last session, but maintains strong technical momentum with bullish moving averages and support at $267. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 EPS expected at $1.1. Revenue growth accelerated to 42% in fiscal 2026, driven by data center products comprising 74% of sales. Analyst consensus remains overwhelmingly bullish with 84% buy ratings and a $327.86 price target, representing 19% upside potential.
Marvell's AI-driven growth story appears compelling with custom chip deals with hyperscalers potentially generating $120 billion in cumulative revenue. However, high valuation multiples (P/E 90.95, P/S 25.77) and recent net losses (-$885M in 2025) present risks. The stock's 210% YTD gain suggests much optimism is priced in, requiring continued execution on the $18 billion fiscal 2028 revenue guidance to justify current levels.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
IQVIA provides clinical research, healthcare data, technology, and consulting services to life sciences companies. Its work supports drug development and commercialization.
Read more on IQV →Marvell Technology is a leading fabless chipmaker focused on networking and storage applications. Marvell serves the data center, carrier, enterprise, automotive, and consumer end markets with processors, optical interconnections, application-specific integrated circuits (ASICs), and merchant silicon for Ethernet applications. The firm is an active acquirer, with five large acquisitions since 2017 helping it pivot out of legacy consumer applications to focus on the cloud and 5G markets.
Read more on MRVL →